{LONGTERMINVESTORS} Techno Funda - Cadila Healthcare.

 

Dear All,

 

Cadila Healthcare

Technical Rationale

Ø  Cadila Healthcare Ltd. is in a long term uptrend channel.

Ø  In medium term stock was in consolidated in the range of 300-450.

Ø  Currently stock is continuing its uptrend and bounced back above 61.8% Fibonacci level at 390.

Ø  Stock is trending towards its upper consolidation level at 450 levels.

Ø  With the stop loss of 340 buy at current level (398) with the target of Fibonacci 161.8% levels at 550.

Ø  Support is at 300 and resistance is at 450.

Fundamental Rationale

Ø  Cadila Healthcare is developing a pipeline of 20 biologics comprising 14 biosimilars and 6 novel biological products; and new drugs in cardio-metabolic disorder, inflammation, pain, and oncology therapeutic areas. Further, it provides animal healthcare products.

Ø  Additionally, the company is developing vaccines that are designed to address infectious diseases, including next-generation influenza, measles-mumps-rubella-varicella, typhoid, DPT-HiB, hepatitis-B, hepatitis-A, hepatitis-E, Japanese encephalitis, Leishmaniasis, Malaria, Haemorrhagic Congo Fever, Ebola, HPV, and combination vaccines.

Ø  Revenue mix by Geography: US (43.7%), India (40.6%) and Rest of the World (15.7%). 

To Unsubscribe from Newsletter Click Here

Regards,

CSEC Research

​ 

--
You received this message because you are subscribed to the Google Groups "LONGTERMINVESTORSRESEARCH" group.
To unsubscribe from this group and stop receiving emails from it, send an email to longterminvestorsresearch+unsubscribe@googlegroups.com.
Visit this group at https://groups.google.com/group/longterminvestorsresearch.
For more options, visit https://groups.google.com/d/optout.